Nootropic Supplements for Cognitive Improvement
Amyloid-β proteins form plaques in the brain that are a hallmark of Alzheimer’s disease. Designed to clear these plaques, the antibody aducanumab is demonstrating early success after a year of testing in a Phase 1b clinical trial, according to interim results published today … [Read more...]
Alzheimer's disease the most common of neurological conditions, affects over 5 million people worldwide. It causes patients to lose their memories and it debilitates them to the point where they need round the clock care. The disease is top five causes of death it has no known … [Read more...]